Bellevue Group AG - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$1,706,000
+108.8%
30,478
+93.0%
0.02%
+100.0%
Q2 2022$817,000
-31.0%
15,794
-3.1%
0.01%
-14.3%
Q1 2022$1,184,000
-39.7%
16,294
-1.8%
0.01%
-30.0%
Q4 2021$1,962,000
-11.9%
16,5940.0%0.02%
-13.0%
Q3 2021$2,226,000
+930.6%
16,594
+4.8%
0.02%
+64.3%
Q4 2018$216,000
-54.0%
15,834
-3.7%
0.01%
-53.3%
Q3 2018$470,000
+2.6%
16,434
-1.8%
0.03%
-23.1%
Q2 2018$458,00016,7340.04%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders